title: Therapeutic considerations concerning a tetanus first use of an anesthetic steroid: succinate of 21 hydroxy-pregnandione.
authors.forename: R
authors.initials: R
authors.lastname: COIRAULT
authors.forename: J
authors.initials: J
authors.lastname: HAINAUT
authors.forename: S
authors.initials: S
authors.lastname: PELAGE
authors.forename: P
authors.initials: P
authors.lastname: MONOD
authors.lastname: MAUBERT
authors.lastname: VIGIER
mesh_terms: D000777:Anesthetics / Q000627:therapeutic use*; D006801:Humans; D013256:Steroids / Q000627:therapeutic use*; D013742:Tetanus / Q000628:therapy*; D013745:Tetanus Toxoid
chemical_list: D000777:Anesthetics; D013256:Steroids; D013745:Tetanus Toxoid
keywords: ANESTHETICS/therapeutic use; STEROIDS/therapeutic use; TETANUS/therapy
vernacular_title: Considérations thérapeutiques concernant un tétanos première utilisation d'un stéroide anesthésique:  succinate de 21 hydroxy-pregnandione.